Literature DB >> 27643459

Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review.

A M Willis1, S K Smith1, B Meiser1, M L Ballinger2, D M Thomas2, M-A Young3.   

Abstract

Evidence suggests that a significant proportion of individuals referred to cancer genetic counselling (GC) do not attend, and thus may not be engaged in adequate cancer risk management. We aimed to review the literature to better understand barriers to accessing GC and how they may be overcome. We conducted a systematic literature search for articles examining factors influencing cancer GC uptake as well as motivators and barriers to GC attendance. Factors were categorised as sociodemographic, psychosocial or clinical. The literature search identified 1413 citations, 35 of which met the inclusion criteria. GC uptake ranged from 19% to 88%. With the exceptions of education level, socioeconomic status, cancer-specific distress, personal cancer diagnosis and actual and perceived risk of cancer, support was lacking for most sociodemographic, clinical and psychosocial factors as predictors of GC uptake. Cost and logistical barriers, emotional concerns, family concerns and low perceived personal relevance were reported as important considerations for those declining GC. We conclude that there is poor understanding of GC and a lack of decision support among those referred to GC. Research into ways of providing education and support to referred individuals will be important as the scope and availability of GC and genetic testing broaden.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  barriers; genetic counselling; hereditary cancer; systematic review; uptake

Mesh:

Year:  2016        PMID: 27643459     DOI: 10.1111/cge.12868

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  22 in total

1.  An Applied Framework in Support of Shared Decision Making about BRCA Genetic Testing.

Authors:  Thomas B Silverman; Gilad J Kuperman; Alejandro Vanegas; Margaret Sin; Jill Dimond; Katherine D Crew; Rita Kukafka
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

2.  Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening.

Authors:  Charles Muller; Sang Mee Lee; William Barge; Shazia M Siddique; Shivali Berera; Gina Wideroff; Rashmi Tondon; Jeremy Chang; Meaghan Peterson; Jessica Stoll; Bryson W Katona; Daniel A Sussman; Joshua Melson; Sonia S Kupfer
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-18       Impact factor: 11.382

Review 3.  Communication of cancer-related genetic and genomic information: A landscape analysis of reviews.

Authors:  Emily B Peterson; Wen-Ying Sylvia Chou; Anna Gaysynsky; Melinda Krakow; Ashley Elrick; Muin J Khoury; Kimberly A Kaphingst
Journal:  Transl Behav Med       Date:  2018-01-29       Impact factor: 3.046

4.  Family Health Leaders: Lessons on Living with Li-Fraumeni Syndrome across Generations.

Authors:  Ashley Pantaleao; Jennifer L Young; Norman B Epstein; Mae Carlson; Renée C Bremer; Payal P Khincha; June A Peters; Mark H Greene; Kevin Roy; Maria Isabel Achatz; Sharon A Savage; Allison Werner-Lin
Journal:  Fam Process       Date:  2019-10-24

5.  Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: Results from the 2015 National Health Interview Survey.

Authors:  Erin Turbitt; Megan C Roberts; Jennifer M Taber; Erika A Waters; Timothy S McNeel; Barbara B Biesecker; William M P Klein
Journal:  Prev Med       Date:  2019-02-25       Impact factor: 4.018

6.  Automatic Genetic Risk Assessment Calculation Using Breast Cancer Family History Data from the EHR compared to Self-Report.

Authors:  Margaret Sin; Julia E McGuinness; Meghna S Trivedi; Alejandro Vanegas; Thomas B Silverman; Katherine D Crew; Rita Kukafka
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

7.  Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.

Authors:  Maija Reblin; Monica L Kasting; Kelli Nam; Courtney L Scherr; Jongphil Kim; Ram Thapa; Cathy D Meade; M Catherine Lee; Tuya Pal; Gwendolyn P Quinn; Susan T Vadaparampil
Journal:  Breast J       Date:  2018-11-28       Impact factor: 2.431

8.  Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.

Authors:  Amanda M Willis; Sian K Smith; Bettina Meiser; Mandy L Ballinger; David M Thomas; Martin Tattersall; Mary-Anne Young
Journal:  J Genet Couns       Date:  2018-02-17       Impact factor: 2.537

9.  Creation and Implementation of an Environmental Scan to Assess Cancer Genetics Services at Three Oncology Care Settings.

Authors:  Erica M Bednar; Michael T Walsh; Ellen Baker; Kimberly I Muse; Holly D Oakley; Rebekah C Krukenberg; Cara S Dresbold; Sandra B Jenkinson; Amanda L Eppolito; Kelly B Teed; Molly H Klein; Nichole A Morman; Elizabeth C Bowdish; Pauline Russ; Emaline E Wise; Julia N Cooper; Michael W Method; John W Henson; Andrew V Grainger; Banu K Arun; Karen H Lu
Journal:  J Genet Couns       Date:  2018-05-16       Impact factor: 2.537

10.  Associations of sociodemographic and clinical factors with gastrointestinal cancer risk assessment appointment completion.

Authors:  Jessica E Ebrahimzadeh; Jessica M Long; Louise Wang; John T Nathanson; Shazia Mehmood Siddique; Anil K Rustgi; David S Goldberg; Bryson W Katona
Journal:  J Genet Couns       Date:  2020-03-30       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.